semaglutide injection patent expiry The upcoming of the in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open What is the patent landscape

Understanding Semaglutide and Its Benefits Semaglutide is an FDA-approved GLP-1 receptor agonist designed for chronic weight management among adults dealing with obesity or those who are overweight with related health conditions

Understanding long-term considerations helps with realistic planning and expectations

Saito S, Cao DY, Okuno A, Li X, Peng Z, Kelel M, Tsuji NM

Moreover, it activates critical neuroprotective transcription factors such as Nrf2, which triggers the expression of antioxidant response elements, enhancing the cells endogenous defense mechanisms against oxidative stress and neuronal degradation [65]